课题基金 / 基金详情

Does UK drug policy require reform? Engaging drug takers into the debate

Does UK drug policy require reform? Engaging drug takers into the debate
英国毒品政策需要改革吗?
批准号:
ES/R007225/1
负责人:
Rebecca Askew
金额:
$30.98万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Drug policy reform is high on the global political agenda. Since the turn of the 21st century, several countries have shifted from prohibition policy. Academics, policy-makers, practitioners, and non-government organisations (NGOs) are discussing (and advocating for) drug policy reform in the UK focussing on the usefulness and relevance of the Misuse of Drugs (MDA) Act 1971 and the Psychoactive Substances Act (PSA) 2016. Yet the voices of drug takers are largely absent from such debate and there is now increasing acknowledgement that contribution from drug takers is required to improve both the policy legitimacy and outcomes (UKDPC, 2012; Lancaster et al., 2014; Lancaster et al, 2015). The proposed research builds on two research projects conducted by the PI that interviewed 60 drug takers. Interviewees from both projects were asked for their opinions on drug policy and the law. Most drug takers were unable to distinguish between different policy approaches and were unclear about the definitions of, 'legalisation', 'regulation' and 'decriminalisation. For example, most were aware that Portugal decriminalised drugs in 2001, but they needed further clarification about what this meant in practice. This research aims to actively involve various drug takers into the drug policy debate by educating them about alternative policy approaches and engaging them in workshop discussions. More investigation is required to understand drug takers' views on policy (specifically on the current prohibitionist framework and alternative models, such as decriminalisation, medicalisation and regulation), how these opinions are formulated and what components of drug policy are important to drug takers. Through the inclusion and analysis of drug takers' experiences and opinions, a drug policy action plan will be formulated. This is necessary to make policy debates more inclusive and facilitate a space to better connect policy to those that it affects. The project has 3 dualistic aims that both empower stigmatised groups (drug takers), whilst improving debates about drug policy reform 1: Improve debates about drug policy reform by involving drug takers' experiences and opinions2: Create a drug action plan using the 'discursive democracy' approach with a range of drug takers 3: Share the findings of the research to key stakeholders to facilitate future interactions about drug policy development These will be achieved through 5 practical objectives:Ob1: Capture the level of drug-takers' knowledge and opinions of law and policy and establish how these opinions have been formulated by undertaking a baseline survey.Ob2: Develop an educational video to outline different policy approaches to improve drug takers' knowledge and understanding. Ob3: Co-ordinate workshops using 'discursive democracy' to generate qualitative data revealing drug-taker's opinions of current and alternative policy and actively encourage their participation in debate.Ob4: Use the findings of the survey and workshops to formulate a comprehensive and informed drug policy action plan.Ob5: Disseminate the drug policy action plan through academic conferences and peer-reviewed articles, and through relevant drug policy NGOs who engage and interact with policy-makers.The potential applications and benefits are to:1. Broaden the debates about UK drug policy reform to include a wide range of people who are directly affected by drug law and policy.2. Help inform, educate and empower the public about political issues, in this instance drug policy.3. Contribute to broader debates about the opportunities and potential for drug policy reform both nationally and globally.4. Provide NGOs with academic research that can be used for evidence and lobbying to policy makers and government.5. The video explaining current and alternative drug policy approaches could be used to educate the general public.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
When self-direction meets conformity: Surfacing Schwartz's 10 basic human values in drug policy dialogue with lived/living experience participants.
当自我导向遇到整合:在与生活/生活经历参与者的毒品政策对话中展示施瓦茨的 10 项基本人类价值观。
DOI: 10.1016/j.drugpo.2023.104257
发表时间: 2023
期刊: The International journal on drug policy
影响因子: --
作者: [Askew R]
通讯作者: Askew R
The importance of PEOPLE who use drugs within drug policy reform debates: Findings from the UK Drug Policy Voices online survey
毒品使用者在毒品政策改革辩论中的重要性:英国毒品政策之声在线调查的结果
DOI: 10.21428/cb6ab371.661773f1
发表时间: 2022
期刊: CrimRxiv
影响因子: --
作者: [Askew R]
通讯作者: Askew R
The importance of PEOPLE who use drugs within drug policy reform debates: Findings from the UK Drug Policy Voices online survey.
毒品政策改革辩论中吸毒者的重要性:英国毒品政策之声在线调查的结果。
DOI: 10.1016/j.drugpo.2022.103711
发表时间: 2022
期刊: The International journal on drug policy
影响因子: --
作者: [Askew R]
通讯作者: Askew R
国内基金
海外基金
LncRNA-lincUK介导邻近基因UK组蛋白修 饰调控褐飞虱繁殖力的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    刘凯
  • 依托单位:
CREKA/rhPro-UK靶向载药微泡在腔内超声场下对静脉血栓的除栓作用及机理研究
EEID:US-UK-China: 新发禽流感病毒的演进与生态传播动力学的前瞻性研究
抗真菌药物UK-2A的组合生物合成研究
  • 批准号:
    31970054
  • 项目类别:
    面上项目
  • 资助金额:
    62.0万元
  • 批准年份:
    2019
  • 负责人:
    瞿旭东
  • 依托单位: